{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T05:55:43Z","timestamp":1778046943857,"version":"3.51.4"},"reference-count":62,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.annemergmed.2014.09.015","type":"journal-article","created":{"date-parts":[[2014,10,23]],"date-time":"2014-10-23T01:00:19Z","timestamp":1414026019000},"page":"410-415","source":"Crossref","is-referenced-by-count":34,"title":["Efficacy of Methylene Blue in an Experimental Model of Calcium Channel Blocker\u2013Induced Shock"],"prefix":"10.1016","volume":"65","author":[{"given":"David H.","family":"Jang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theodore C.","family":"Bania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.annemergmed.2014.09.015_bib1","first-page":"1281","article-title":"Increases in age-group-specific injury mortality\u2014United States, 1999-2004","volume":"56","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1081\/CLT-100102460","article-title":"Poisoning-related visits to emergency departments in the United States, 1993-1996","volume":"37","author":"McCaig","year":"1999","journal-title":"J\u00a0Toxicol Clin Toxicol"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib3","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1080\/15563650802559632","article-title":"2007 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 25th annual report","volume":"46","author":"Bronstein","year":"2008","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib4","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3109\/15563650903438566","article-title":"2008 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 26th annual report","volume":"47","author":"Bronstein","year":"2009","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3109\/15563650.2010.543906","article-title":"2009 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 27th annual report","volume":"48","author":"Bronstein","year":"2010","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib6","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3109\/15563650.2011.635149","article-title":"2010 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th annual report","volume":"49","author":"Bronstein","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3109\/15563650.2012.746424","article-title":"2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th annual report","volume":"50","author":"Bronstein","year":"2012","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0196-0644(05)80202-1","article-title":"A\u00a0one-year evaluation of calcium channel blocker overdoses: toxicity and treatment","volume":"22","author":"Ramoska","year":"1993","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib9","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJM199911043411907","article-title":"Calcium-antagonist drugs","volume":"341","author":"Abernethy","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib10","first-page":"580","article-title":"An 11-year retrospective comparison of dihydropyridines and non-dihydropyridine calcium channel blockers","volume":"50","author":"Jang","year":"2012","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13181-011-0207-x","article-title":"Amlodipine fatality in an infant with postmortem blood levels","volume":"8","author":"Spiller","year":"2012","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib12","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0735-6757(98)90011-0","article-title":"Amlodipine overdose causes prolonged calcium channel blocker toxicity","volume":"16","author":"Adams","year":"1998","journal-title":"Am J Emerg Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib13","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1093\/jat\/30.5.346","article-title":"Two cases of fatal amlodipine overdose","volume":"30","author":"Sklerov","year":"2006","journal-title":"J\u00a0Anal Toxicol"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib14","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0196-0644(05)80997-7","article-title":"The use of glucagon in a case of calcium channel blocker overdose","volume":"22","author":"Doyon","year":"1993","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib15","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S0196-0644(05)81624-5","article-title":"Intravenous calcium before verapamil to prevent hypotension","volume":"20","author":"Dolan","year":"1991","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib16","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1081\/CLT-120023761","article-title":"Glucagon in beta-blocker and calcium channel blocker overdoses: a systematic review","volume":"41","author":"Bailey","year":"2003","journal-title":"J\u00a0Toxicol Clin Toxicol"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib17","doi-asserted-by":"crossref","unstructured":"Osthoff M, Bernsmeier C, Marsch SC, et al. Levosimendan as treatment option in severe verapamil intoxication: a case report and review of the literature. Case Rep Med. 2010; http:\/\/dx.doi.org\/10.1155\/2010\/546904.","DOI":"10.1155\/2010\/546904"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib18","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0022-3565(25)39488-7","article-title":"Insulin is a superior antidote for cardiovascular toxicity induced by verapamil in the anesthetized canine","volume":"267","author":"Kline","year":"1993","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib19","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3109\/15563650.2011.582471","article-title":"High-dose insulin therapy in beta-blocker and calcium channel-blocker poisoning","volume":"49","author":"Engebretsen","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF03160973","article-title":"Levosimendan does not improve survival time in a rat model of verapamil toxicity","volume":"5","author":"Abraham","year":"2009","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(82)90912-6","article-title":"Lack of response to intravenous calcium in severe verapamil poisoning","volume":"2","author":"Crump","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/BF03160947","article-title":"A\u00a0fatal case of iatrogenic hypercalcemia after calcium channel blocker overdose","volume":"4","author":"Sim","year":"2008","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib23","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1592\/phco.30.7.702","article-title":"Methylene blue for the treatment of septic shock","volume":"30","author":"Paciullo","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib24","first-page":"582","article-title":"The use of methylene blue in the treatment of anaphylactic shock induced by compound 48\/80: experimental studies in rabbits","volume":"23","author":"Buzato","year":"2005","journal-title":"Shock"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/S0196-0644(97)70152-5","article-title":"Methylene blue in anaphylactic shock","volume":"30","author":"Evora","year":"1997","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib26","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1097\/00003246-199606000-00043","article-title":"Effects of methylene blue in septic shock","volume":"24","author":"Koch","year":"1996","journal-title":"Crit Care Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib27","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1553-2712.2008.00259.x","article-title":"Determining the optimal dose of intravenous fat emulsion for the treatment of severe verapamil toxicity in a rodent model","volume":"15","author":"Perez","year":"2008","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib28","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1111\/j.1553-2712.2011.01217.x","article-title":"L-Carnitine increases survival in a murine model of severe verapamil toxicity","volume":"18","author":"Perez","year":"2011","journal-title":"Acad Emerg Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib29","article-title":"The novel development of an experimental model of dihydropyridine calcium channel blocker poisoning using intravenous amlodipine","volume":"2","author":"Jang","year":"2013","journal-title":"Int J Cardiovasc Res"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib30","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.niox.2010.01.006","article-title":"A\u00a0dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock","volume":"22","author":"Juffermans","year":"2010","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib31","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1097\/00003246-200110000-00002","article-title":"Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study","volume":"29","author":"Kirov","year":"2001","journal-title":"Crit Care Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib32","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1007\/s13181-013-0298-7","article-title":"Methylene blue for distributive shock: a potential new use of an old antidote","volume":"9","author":"Jang","year":"2013","journal-title":"J\u00a0Med Toxicol"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib33","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1093\/ndt\/16.7.1436","article-title":"Methylene blue, a nitric oxide inhibitor, prevents haemodialysis hypotension","volume":"16","author":"Peer","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib34","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0006-2952(93)90072-5","article-title":"Inhibition of nitric oxide synthesis by methylene blue","volume":"45","author":"Mayer","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib35","first-page":"35","article-title":"Inhibition by methylene blue of the l-arginine metabolism to l-citrulline coupled with nitric oxide synthesis in cultured endothelial cells","volume":"82","author":"Shimizu","year":"1993","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib36","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S1081-1206(10)60545-5","article-title":"Role of nitric oxide production in anaphylaxis and its relevance for the treatment of anaphylactic hypotension with methylene blue","volume":"99","author":"Evora","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/00003246-200301000-00028","article-title":"Combination of intravenously infused methylene blue and inhaled nitric oxide ameliorates endotoxin-induced lung injury in awake sheep","volume":"31","author":"Kirov","year":"2003","journal-title":"Crit Care Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib38","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/01.CIR.97.6.576","article-title":"Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent","volume":"97","author":"Zhang","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib39","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/00005344-200202000-00007","article-title":"Paradoxical release of nitric oxide by an L-type calcium channel antagonist, the R+ enantiomer of amlodipine","volume":"39","author":"Zhang","year":"2002","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib40","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0008-6363(03)00505-4","article-title":"Amlodipine activates the endothelial nitric oxide synthase by altering phosphorylation on Ser1177 and Thr495","volume":"59","author":"Lenasi","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib41","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/sj.bjp.0704753","article-title":"Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide\u2013 and kinin-dependent mechanism","volume":"136","author":"Xu","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj3570593","article-title":"Nitric oxide synthases: structure, function and inhibition","volume":"357","author":"Alderton","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib43","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1042\/bst0210330","article-title":"Pathological implications of nitric oxide, superoxide and peroxynitrite formation","volume":"21","author":"Beckman","year":"1993","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib44","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1590\/S0100-879X1999001200009","article-title":"Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effects on pulmonary function after a short infusion of methylene blue","volume":"32","author":"Weingartner","year":"1999","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0952-7915(91)90079-G","article-title":"Role of nitric oxide synthesis in macrophage antimicrobial activity","volume":"3","author":"Nathan","year":"1991","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib46","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.CCM.0000104209.07273.FC","article-title":"Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002)","volume":"32","author":"Watson","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib47","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1084\/jem.176.4.1175","article-title":"N omega-amino-L-arginine, an inhibitor of nitric oxide synthase, raises vascular resistance but increases mortality rates in awake canines challenged with endotoxin","volume":"176","author":"Cobb","year":"1992","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0883-9441(98)90001-6","article-title":"Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange","volume":"13","author":"Andresen","year":"1998","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib49","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01706481","article-title":"Methylene blue increases systemic vascular resistance in human septic shock. Preliminary observations","volume":"18","author":"Schneider","year":"1992","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib50","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/BCR.0b013e31816677b5","article-title":"Methylene blue in the treatment of vasoplegia following severe burns","volume":"29","author":"Jaskille","year":"2008","journal-title":"J\u00a0Burn Care Res"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib51","first-page":"515","article-title":"Methylene blue enhancement of resuscitation after refractory hemorrhagic shock","volume":"57","author":"Ghiassi","year":"2004","journal-title":"J\u00a0Trauma"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib52","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/CCM.0b013e318267667b","article-title":"Methylene blue and epinephrine: a synergetic association for anaphylactic shock treatment","volume":"41","author":"Zheng","year":"2013","journal-title":"Crit Care Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib53","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-007402","article-title":"Methylene blue reverses recalcitrant shock in beta-blocker and calcium channel blocker overdose","volume":"2013","author":"Aggarwal","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib54","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.annemergmed.2011.02.025","article-title":"Methylene blue in the treatment of refractory shock from an amlodipine overdose","volume":"58","author":"Jang","year":"2011","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib55","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0022-3476(61)80064-4","article-title":"Methylene blue induced cyanosis and acute hemolytic anemia complicating the treatment of methemoglobinemia","volume":"58","author":"Goluboff","year":"1961","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib56","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1007\/BF01700666","article-title":"Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock","volume":"21","author":"Gachot","year":"1995","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib57","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1056\/NEJMra041867","article-title":"The serotonin syndrome","volume":"352","author":"Boyer","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib58","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/1078155211433231","article-title":"Suspected serotonin syndrome in a patient being treated with methylene blue for ifosfamide encephalopathy","volume":"18","author":"McDonnell","year":"2012","journal-title":"J\u00a0Oncol Pharm Pract"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib59","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1136\/jnnp.2009.172221","article-title":"Serotonin syndrome following methylene blue infusion: a rare complication of antidepressant therapy","volume":"81","author":"Heritier Barras","year":"2010","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib60","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0033-3182(10)70685-X","article-title":"The role of methylene blue in serotonin syndrome: a systematic review","volume":"51","author":"Ng","year":"2010","journal-title":"Psychosomatics"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib61","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12028-009-9206-z","article-title":"Methylene blue\u2013associated serotonin syndrome: a \u201cgreen\u201d encephalopathy after parathyroidectomy","volume":"11","author":"Rowley","year":"2009","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.annemergmed.2014.09.015_bib62","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.taap.2011.12.005","article-title":"Azure B, a metabolite of methylene blue, is a high-potency, reversible inhibitor of monoamine oxidase","volume":"258","author":"Petzer","year":"2012","journal-title":"Toxicol Appl Pharmacol"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064414013018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064414013018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,5]],"date-time":"2025-05-05T11:21:21Z","timestamp":1746444081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064414013018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":62,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0196064414013018"],"URL":"https:\/\/doi.org\/10.1016\/j.annemergmed.2014.09.015","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}